Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1310293
European Journal of Endocrinology, Vol 131, Issue 3, 293-301
Copyright © 1994 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scharla, S. H
Right arrow Articles by Linkhart, T. A
Right arrow Search for Related Content
PubMed
Right arrow Articles by Scharla, S. H
Right arrow Articles by Linkhart, T. A

Effect of tumor necrosis factor-{alpha} on the expression of insulin-like growth factor I and insulin-like growth factor binding protein 4 in mouse osteoblasts

Stephan H Scharla, Donna D Strong, Subburaman Mohan, Thierry Chevalley and Thomas A Linkhart

Scharla SH, Strong DD, Mohan S, Chevalley T, Linkhart TA. Effect of tumor necrosis factor-{alpha} on the expression of insulin-like growth factor I and insulin-like growth factor binding protein 4 in mouse osteoblasts. Eur J Endocrinol 1994;131:293–301. ISSN 0804–4643

Tumor necrosis factor-{alpha} (TNF-{alpha}) is a cytokine produced by immune cells, which has multiple effects on bone cells and is therefore thought to mediate changes in bone metabolism occurring during inflammation. In the present study we have investigated the effect of TNF-{alpha} on the secretion of insulin-like growth factor I (IGF-I) and IGF binding protein 4 (IGFBP-4) by clonal mouse osteoblasts (MC3T3-E1 cells) using subconfluent in vitro cultures and serum-free conditions. The IGF-I was determined by radioimmunoassay under conditions eliminating the interference of IGFBPs. Treatment of MC3T3-E1 cultures with TNF-{alpha} for 24 h resulted in a dose-dependent decrease in IGF-I secretion (maximally to 34 ± 9.7% of control with 60 pmol/l TNF-{alpha}; mean ± SD). The TNF-{alpha} treatment also resulted in decreased messenger ribonucleic acid (mRNA) levels of IGF-I at 4 and 24 h, as detected by Northern analysis. Because basal secretion of IGFBPs is very low in MC3T3-E1 cells, effects of TNF-{alpha} on IGFBP secretion were studied in cultures in which IGFBP-4 expression was increased by calcitriol (1,25(OH)2D3) treatment. The presence of TNF-{alpha} (600 pmol/l) inhibited this calcitriol-induced stimulation of IGFBP-4 mRNA levels from 4 h onwards, with complete inhibition of the calcitriol effect occurring at 24 h. We also observed a dose-dependent inhibition of calcitriol-stimulated IGFBP-4 secretion into the culture medium (as detected by Western ligand blot), with the maximal inhibition occurring with 600 pmol/l TFN-{alpha} to 25 ± 7% of control levels. These TNF-{alpha} effects were not prevented by indomethacin treatment, suggesting that they are not dependent on prostaglandins. The DNA synthesis was reduced to 62 ± 8% of the control value by 600 pmol/l TNF-{alpha}. We conclude that secretion of IGFs and IGFBPs by osteoblasts can be modulated by TNF-{alpha}, which in turn may be responsible for some of the known effects of TNF-{alpha} on osteoblastic cell proliferation and differentiation.

Stephan H Scharla, Klinik am Kurpark, Schussenrieder Strasse 5, D-88326 Anlendorf, Germany




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
W. A. Price, B. M. Moats-Staats, and A. D. Stiles
Pro- and Anti-inflammatory Cytokines Regulate Insulin-like Growth Factor Binding Protein Production by Fetal Rat Lung Fibroblasts
Am. J. Respir. Cell Mol. Biol., March 1, 2002; 26(3): 283 - 289.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Gilbert, X. He, P. Farmer, S. Boden, M. Kozlowski, J. Rubin, and M. S. Nanes
Inhibition of Osteoblast Differentiation by Tumor Necrosis Factor-{alpha}
Endocrinology, November 1, 2000; 141(11): 3956 - 3964.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. J. Chae, S. W. Chae, J. S. Kang, B. G. Bang, S. B. Cho, R. K. Park, H. S. So, Y. K. Kim, H. M. Kim, and H. R. Kim
Dexamethasone Suppresses Tumor Necrosis Factor-{alpha}-Induced Apoptosis in Osteoblasts: Possible Role for Ceramide
Endocrinology, August 1, 2000; 141(8): 2904 - 2913.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Anwar, A.A. Zahid, K.J. Scheidegger, M. Brink, and P. Delafontaine
Tumor Necrosis Factor-{alpha} Regulates Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Expression in Vascular Smooth Muscle
Circulation, March 12, 2002; 105(10): 1220 - 1225.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 European Society of Endocrinology.